Accelerating the development of biomarkers for drug safety : workshop summary

Accelerating the development of biomarkers for drug safety workshop summary

"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...

Descripción completa

Detalles Bibliográficos
Autor principal: Institute of Medicine (U.S.).
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation (-), National Research Council (U.S.). Planning Committee for Assessing and Accelerating the Development of Biomarkers for Drug Safety : a Workshop, Assessing and Accelerating the Development of Biomarkers for Drug Safety. Workshop
Otros Autores: Giffin, Robert B. (-), Olson, Steve, 1956-, Robinson, Sally
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press c2009.
Edición:1st ed
Materias:
Biochemical markers > Congresses.
Drugs > Safety measures > Congresses.
Drugs > Testing > Congresses.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622339306719
Tabla de Contenidos:
  • Overview Of key issues
  • Cardiac safety biomarkers
  • Assessing and predicting kidney safety
  • Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials
  • Future considerations.

Ejemplares similares